Mylan names Coury executive chairman again
Mylan NV on Wednesday named Chairman Robert J. Coury to the role of executive chairman as the company deals with not only the COVID-19 global pandemic, but also works to complete a merger with the Upjohn unit of Pfizer Inc. It's the second time Coury has been executive chairman of the pharmaceutical company, which is now headquartered in The Netherlands but is run from its global center at Southpointe in Canonsburg. The longtime Mylan board member was CEO from 2002 to 2012 and was then executive… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 15, 2020 Category: Biotechnology Authors: Paul J. Gough Source Type: news

Mylan names Coury executive chairman again
Mylan NV on Wednesday named Chairman Robert J. Coury to the role of executive chairman as the company deals with not only the COVID-19 global pandemic, but also works to complete a merger with the Upjohn unit of Pfizer Inc. It's the second time Coury has been executive chairman of the pharmaceutical company, which is now headquartered in The Netherlands but is run from its global center at Southpointe in Canonsburg. The longtime Mylan board member was CEO from 2002 to 2012 and was then executive… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2020 Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news

One Drop ’s Latest Acquisition Takes it Deeper into Telemedicine
Medtech deals are still happening despite the economic pressures brought on by the coronavirus pandemic. The latest deal sees digital health specialist One Drop acquiring all the assets and intellectual property of Sano Intelligence for an undisclosed sum.   San Francisco, CA-based Sano had developed a biometric sensor that tells a person important things about their health by revealing how the person’s body metabolizes glucose. The deal between the two was structured as an asset purchase with several members of the Sano team slated to join One Drop.   New York-based One Drop said ...
Source: MDDI - April 14, 2020 Category: Medical Devices Tags: Digital Health COVID-19 Source Type: news

FirstMedCommsJobs: The Allegro training programme – an update
To celebrate the Allegro 100 milestone, Katie Johnson (Talent Acquisition Associate) and Eleanor Thomas (Medical Writer and a graduate of the Allegro programme) joined Peter Llewelyn for a... The post FirstMedCommsJobs: The Allegro training programme – an update appeared first on Ashfield Healthcare. (Source: Ashfield Healthcare News)
Source: Ashfield Healthcare News - April 14, 2020 Category: Pharmaceuticals Authors: Ashfield Healthcare Communications Source Type: news

Adventist Health acquires community health planning venture
A recent acquisition by Roseville-based Adventist Health could see the health system play a larger role in community planning and environmental health. This week, Adventist announced that it's acquired Blue Zones LLC, a Minneapolis-based company that researches and assesses community health. Blue Zones originally started as a project for National Geographic, which was written by Blue Zone's founder, Dan Buettner, in 2005. The company name is ba sed on the concept that there are five “blue zones”… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 10, 2020 Category: Pharmaceuticals Authors: Felicia Alvarez Source Type: news

Adventist Health acquires community health planning venture
A recent acquisition by Roseville-based Adventist Health could see the health system play a larger role in community planning and environmental health. This week, Adventist announced that it's acquired Blue Zones LLC, a Minneapolis-based company that researches and assesses community health. Blue Zones originally started as a project for National Geographic, which was written by Blue Zone's founder, Dan Buettner, in 2005. The company name is ba sed on the concept that there are five “blue zones”… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 10, 2020 Category: Biotechnology Authors: Felicia Alvarez Source Type: news

Pentagon will accelerate PPE production with faster, more nimble contracts
With caps on the prototype acquisition vehicle lifted, defense officials want new ideas from industry on how to produce and decontaminate protective gear. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 9, 2020 Category: Pharmaceuticals Authors: Carten Cordell Source Type: news

Organovo Says No to Tarveda Merger
Organovo Holdings said it has terminated its merger agreement with Tarveda Therapeutics. The San Diego, CA-based company originally submitted the proposal to merge with Tarveda Therapeutics late last year. Watertown, MA-based Tarveda is a clinical-stage biopharmaceutical company developing a new class of potent and selective precision oncology medicines, which it refers to as Pentarin miniature drug conjugates. The merger proposal, which would have been an all-stock transaction, was voted down during a recent special meeting of stockholders. If the merger had gone through the combined company would have operated under the ...
Source: MDDI - April 9, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Why 'Kimtirement' is a real thing with this longtime biotech exec
After her company completed a merger in November, people told Kim Popovits to take six months off before considering anything. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 8, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Regulator: Circle merger would reduce competition in two areas
The competition regulator has said it will allow the merger of two private hospital groups if its concerns about reduced competition in two regions are resolved. (Source: HSJ)
Source: HSJ - April 8, 2020 Category: UK Health Source Type: news

Red Nucleus Acquires R & D Software Solution
Acquisition Creates Industry Game Changer(PRWeb April 08, 2020)Read the full story at https://www.prweb.com/releases/red_nucleus_acquires_r_d_software_solution/prweb17032556.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 8, 2020 Category: Pharmaceuticals Source Type: news

Allurion Files for PMA Submission of Elipse Gastric Balloon
Allurion Technologies is one step closer to having its Elipse gastric balloon enter the U.S. market. The Natick, MA-based company announced the PMA submission of the device early Tuesday. The submission comes hot on the heels of Allurion raising $34 million in new funding through a securities financing and a growth capital term loan. Allurion also announced the hiring of Joyce Johnson as VP, Regulatory Affairs and Quality Assurance. “Joyce comes to Allurion at an opportune and exciting time as we work towards receiving US regulatory approval from the FDA for the Elipse Balloon,” said Sha...
Source: MDDI - April 7, 2020 Category: Medical Devices Authors: Omar Ford Tags: Implants Regulatory and Compliance Source Type: news

Non-surgical Device for BPH Wins De Novo from FDA
FDA has granted de novo classification to a non-surgical device for the minimally invasive treatment of Benign Prostatic Hyperplasia (BPH). The iTind device was developed by Or Akiva, Israel-based Medi-Tate. However, Olympus holds the exclusive right to distribute iTind in the U.S. Here’s how iTind works. The flexible three-strut nitinol device can be placed during an in-office procedure. It expands over five days to create channels that allow urine to flow and reshape the prostate. In a release, Nacho Abia, COO of Olympus Corporation and CEO of Olympus Corporation of the Americas said, "Our investme...
Source: MDDI - April 6, 2020 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Source Type: news

More Medical Device Businesses Impacted by COVID-19
The uncertainty surrounding COVID-19 is making it difficult for public companies to accurately forecast 2020 earnings. Irvine, CA-based Endologix recently joined a growing list of medical device companies that have withdrawn previously-reported financial guidance for the year. The company makes endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once an AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. Endologix said AAA p...
Source: MDDI - April 6, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

When corporate acquisitions mean fewer ventilators
Companies often purchase competitors just to shut them down. This may be partially responsible for a shortage of ventilators in the United States. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 3, 2020 Category: Universities & Medical Training Source Type: news

COVID-19 Could Hurt Orthopedic Companies in More Ways than One
Any medical procedure that can be deffered until after the coronavirus pandemic is over will be. That means lower procedure volumes for hospitals and medical practices, which translates into lower revenue for medical device companies. One sector of the industry that stands to be heavily impacted by this is orthopedics. Canaccord Genuity analyst Kyle Rose surveyed orthopedic/spine surgeons to assess the impact on treatment patterns and practice viability. As expected, most of the 50 respondents (60%) said their organizations were defering or postponing all procedures, and about a third of respondents...
Source: MDDI - April 2, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Orthopedics Source Type: news

Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio
BOSTON, April 2, 2020 -- (Healthcare Sales & Marketing Network) -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced that it has... Devices, Mergers & Acquisitions Haemonetics, enicor GmbH, ClotPro (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 2, 2020 Category: Pharmaceuticals Source Type: news

COVID-19 Could Hurt Orthopedics Companies in More Ways than One
Any medical procedure that can be deffered until after the coronavirus pandemic is over will be. That means lower procedure volumes for hospitals and medical practices, which translates into lower revenue for medical device companies. One sector of the industry that stands to be heavily impacted by this is orthopedics. Canaccord Genuity analyst Kyle Rose surveyed orthopedic/spine surgeons to assess the impact on treatment patterns and practice viability. As expected, most of the 50 respondents (60%) said their organizations were defering or postponing all procedures, and about a third of respondents...
Source: MDDI - April 2, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Orthopedics Source Type: news

Mechanism to Reduce Medical Supply Shortfalls During Pandemics
Source: RAND Corporation. Published: 4/2020. If different regions face pandemic peaks at different points in time, supply shortfalls in regions suffering high infection caseloads (hot spots) can potentially be reduced by minimizing idle inventory and acquisitions of new supplies in regions with contemporaneously low infection caseloads (cool spots). This 16-page report discusses a potential backstopping mechanism for addressing that inefficient distribution. It also offers observations on how to evaluate whether the proposed mechanism could provide benefits over alternative responses in the ongoing coronavirus disease 201...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 1, 2020 Category: International Medicine & Public Health Source Type: news

Talcum brand Nycil gets into Sanitiser business
The sanitiser product is also the first big launch on the Heinz portfolio after its acquisition in 2018. Ahmedabad-based Zydus Wellness with Cadila Healthcare added brands like Complan, Glucon-D and Nycil to the portfolio after the acquisition of Heinz India. (Source: The Economic Times)
Source: The Economic Times - March 31, 2020 Category: Consumer Health News Source Type: news

COVID-19 News Central
Medical device companies play an essential role in combatting the novel coronavirus (COVID-19). To help, MD+DI is tracking developments in evolving regulator policies, support from medtech suppliers, and the progress being made in meeting urgent needs for medical supplies. Click on the links below for details, and monitor this page for updates. Regulations, Policies, and Government ResponseHow CDRH Is Responding to COVID-19Proposal to Postpone EU Medical Device Regulation UnderwayFDA Warns Against Fraudulent COVID-19 Tests and TreatmentsFDA Issues Emergency Guidance for Non-Invasive Remote Monitoring DevicesFDA Issues Enfo...
Source: MDDI - March 29, 2020 Category: Medical Devices Authors: MD+DI Staff Tags: Business Source Type: news

Fangs for the memories? A survey of pain in snakebite patients does not support a strong role for defense in the evolution of snake venom composition - Ward-Smith H, Arbuckle K, Naude A, W üster W.
Animals use venoms for multiple purposes, most prominently for prey acquisition and self-defense. In snakes, venom composition often evolves as a result of selection for optimization for local diet. However, whether selection for a defensive function has a... (Source: SafetyLit)
Source: SafetyLit - March 28, 2020 Category: International Medicine & Public Health Tags: Non-Human Animals and Insects Source Type: news

Medtech in a Minute: COVID-19 Impacts Business, Regulation, and More
EC pushes to postpone new medical device regulations  As the deadline for the new medical device regulations to go into force in the European Union rapidly approaches (end of May), the European Commission (EC) is looking to postpone the new regulations by one year. The delay would allow national authorities and industry to focus on urgen priorities related to the coronavirus (COVID-19) crisis, said a spokesman for the EC.   Elon Musk Talks Ventilators with Medtronic Tweets from Elon Musk and Medtronic attracted a lot of positive and negative attention. Musk said he "had a long engin...
Source: MDDI - March 28, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

ViacomCBS was facing a rough year. How the coronavirus made it even worse
ViacomCBS stock is down 68% since the merger in early December (Source: L.A. Times - Health)
Source: L.A. Times - Health - March 27, 2020 Category: Consumer Health News Authors: Meg James Source Type: news

NLM Technical Bulletin, Mar-Apr 2020, New Library Services Platform to Support Library Operations
As part of the modernization of NLM 19s infrastructure, we will be replacing the Voyager Integrated Library System with the Library Services Platform, Alma. Voyager was implemented at NLM in 1998 for library management operations, including acquisitions, cataloging, collection management, circulation, and preservation. For enhanced integration of, and public access to, the NLM collection, NLM will also replace WebVoyage Classic (LocatorPlus) and SFX OpenURL link resolver with PrimoVE. (Source: NLM Technical Bulletin)
Source: NLM Technical Bulletin - March 27, 2020 Category: Databases & Libraries Source Type: news

Experts condemn Clive Palmer-funded ads claiming hydroxychloroquine can cure coronavirus
Queensland businessman has pledged to fund 1m doses, despite warnings it can lead to heart attacks, eye damage and comaProminent advertisements paid for by former federal politician Clive Palmer which promote a malaria drug as a potential “cure” for Covid-19 are “ethically immoral” according to Prof Peter Collignon, a former World Health Organization advisor who worked on Australia’s response to the Sars virus.The two-page ad in the Australian states the drug, hydroxychloroquine, when combined with another medication could “wipe out the virus in test tubes”. The ad says Palmer &nda...
Source: Guardian Unlimited Science - March 27, 2020 Category: Science Authors: Melissa Davey Tags: Coronavirus outbreak Clive Palmer Health Australia news Infectious diseases Medical research Source Type: news

Obalon Mulling Over Strategic Options Amid COVID-19 Crisis
Obalon Therapeutics is exploring financial and strategic alternatives because of the impact of COVID-19 on elective procedures. The weight loss solutions company said on Wednesday that these alternatives could include equity or debt financing; a sale of the company; a business combination; or a merger or a reverse merger with another party. Obalon has developed a gas-filled intragastric balloon system that treats obesity. The device won a nod from FDA back in 2016. The company has engaged Canaccord Genuity as its advisor.   Nearly a year ago, Obalon made a similar play, albei...
Source: MDDI - March 27, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Implants Source Type: news

Thermo Fisher Granted CE Mark for COVID-19 Test
Thermo Fisher Scientific is bringing its diagnostic detects nucleic acid from SARS-CoV-2, the virus that causes COVID-19, to Europe. The Waltham, MA-based company said earlier today it had received CE mark for the test. The test uses Applied Biosystems TaqPath Assay technology and is designed to provide patient results within four hours of a sample being received by a lab. The estimated time-to-result also includes time for sample preparation and instrument analysis. "The CE mark certification is an important step in combatting the outbreak of COVID-19 across Europe," said Marc Casper, chairman, president and CEO...
Source: MDDI - March 26, 2020 Category: Medical Devices Authors: Omar Ford Tags: IVD Regulatory and Compliance Source Type: news

Elevar Therapeutics Acquires Global Rights to European Approved Apealea(R) from Oasmia Pharmaceutical
SALT LAKE CITY, March 25, 2020 -- (Healthcare Sales & Marketing Network) -- Elevar Therapeutics, Inc., a fast-growing biopharmaceutical company focused on promising therapies for unmet medical needs in cancer, announced today an agreement with Swedish-bas... Biopharmaceuticals, Oncology, Acquisitions Elevar Therapeutics, Oasmia Pharmaceutical, Apealea, paclitaxel (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 25, 2020 Category: Pharmaceuticals Source Type: news

HHS Awards $100 Million to Health Centers for COVID-19 Response
The U.S. Department of Health and Human Services (HHS) awarded $100 million to 1,381 health centers through the Coronavirus Preparedness and Response Supplemental Appropriations Act. The funding will support HRSA-funded health centers with their emergency planning and response efforts, including screening and testing needs, the acquisition of medical supplies, and telehealth capacity during the coronavirus pandemic. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - March 24, 2020 Category: Rural Health Source Type: news

Masimo ’s Latest Acquisition Could Help in the Fight Against COVID-19
Masimo’s new acquisition could aid in the fight to help manage coronavirus (COVID-19) patients. The Irvine, CA-based company said late last week that it had entered into a definitive agreement to acquire ventilation company specialist, TNI medical AG for an undisclosed sum. The deal is set to close in 2Q20 and Masimo expects to fund the acquisition with existing cash on hand and expects the transaction to have an immaterial impact to net earnings in 2020. Würzburg, Germany-based TNI has designed the softFlow technology to provide high flow, warmed, and humidified respiratory gases to sponta...
Source: MDDI - March 24, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Test Shows How Lung Cancer Patients Respond to Therapy
Oncocyte said it has completed Clinical Laboratory Improvements Amendments (CLIA) validation for its DetermaIO. The Irvine, CA-based company said the diagnostic, which was previously known as the Insight Genetics IM Score Test, is used in lung cancer patients to identify individuals more or less likely to respond to anti-PD-1/PD-LI immunotherapy. Oncocyte said the DetermaIO test differentiates itself from the current leading immunotherapy diagnostic tests by having the capability to determine if the immune microenvironment is active (“hot”) or quiescent (“coldâ...
Source: MDDI - March 20, 2020 Category: Medical Devices Authors: Omar Ford Tags: IVD Regulatory and Compliance Source Type: news

FDA offers mammo facility guidance for COVID-19
The U.S. Food and Drug Administration (FDA) has posted guidance for mammography...Read more on AuntMinnie.comRelated Reading: FDA cuts back on U.S. inspections due to COVID-19 FDA pauses international inspections due to COVID-19 FDA recognizes AI-based image acquisition software FDA proposes electronic 510(k) submission template FDA seeks help to prevent vaping-related lung injuries (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 19, 2020 Category: Radiology Source Type: news

FDA cuts back on U.S. inspections due to COVID-19
In response to the COVID-19 outbreak, the U.S. Food and Drug Administration...Read more on AuntMinnie.comRelated Reading: FDA pauses international inspections due to COVID-19 FDA recognizes AI-based image acquisition software FDA proposes electronic 510(k) submission template FDA seeks help to prevent vaping-related lung injuries FDA takes action to counter novel coronavirus (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 19, 2020 Category: Radiology Source Type: news

The Sanders Trust acquires New Orleans rehabilitation hospital
The Sanders Trust has acquired the $29 million dollar Cobalt Rehabilitation Hospital in New Orleans, expanding the company ’s reach to Louisiana.  The hospital is a 60-bed facility built in 2016 and was operated by Cobalt Rehabilitation until late 2019, when Dallas-based Curahealth completed the acquisition of all Cobalt operations.  According to The Sanders Trust, it has acquired the real estate and the 65,345-sq uare-foot facility; it will continue to be operated by Curahealth/Cobalt on a long-term… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2020 Category: Pharmaceuticals Authors: Tyler Patchen Source Type: news

Roche Annual General Meeting 2020
Basel, 17 March 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its shareholders approved all proposals of the Board of Directors at its ordinary Annual General Meeting (AGM). On the basis of COVID-19 Ordinance 2 of the Swiss Federal Council, no shareholders were admitted to attend the General Meeting in person. Roche had already recommended on March 10 that shareholders should delegate their votes to the independent proxy. The independent proxy represented 85.47 % of the total 160,000,000 shares. The Management Report, the Financial Statements and the Consolidated Financial Statements for 2019 were ap...
Source: Roche Investor Update - March 17, 2020 Category: Pharmaceuticals Source Type: news

Rite Aid To Rebrand PBM And Consider Acquisitions
The drugstore chain Rite Aid is rebranding its pharmacy benefit management company as “elixir” with plans to grow it by attracting new clients in the middle market and future acquisitions of other PBMs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 17, 2020 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Operational applications drive AI adoption in radiology
When talking about artificial intelligence (AI) in radiology, one immediately...Read more on AuntMinnie.comRelated Reading: AI predicts final infarct lesion for stroke on MRI New credentialing body formed for AI FDA recognizes AI-based image acquisition software AI may help improve management of stroke patients AI finds infarction in stroke patients on unenhanced CT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 17, 2020 Category: Radiology Source Type: news

Dispelling doubts about practice mergers in the Black Country
The push towards delivering primary care at scale involves a pooling of many interests. (Source: NHS Networks)
Source: NHS Networks - March 16, 2020 Category: UK Health Source Type: news

ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
Provides ADVANZ PHARMA with an immediate and direct commercial presence in Germany, France, Spain, Italy, and the Benelux region, while strengthening its existing presence in the Nordics and the United Kingdom Further diversifies ADVANZ PHARMA's portfol... Biopharmaceuticals, Mergers & Acquisitions ADVANZ PHARMA, Correvio Pharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 16, 2020 Category: Pharmaceuticals Source Type: news

ADVANZ PHARMA to Acquire Correvio
Acquisition Expected to Have a Total Purchase Price of Approximately US$76 Million Including the Repayment of Certain Correvio Indebtedness ADVANZ PHARMA Intends to Pay for the Acquisition with Cash on Hand Provides ADVANZ PHARMA with an Immediate an... Biopharmaceuticals, Mergers & Acquisitions Correvio Pharma, ADVANZ PHARMA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 16, 2020 Category: Pharmaceuticals Source Type: news

State to consider new dialysis center, $7M nursing home sale
A group of downstate nursing home operators plans to spend $7 million to enter the Western New York market through the acquisition of an Allegany County facility. Highland Operations LLC is working to take over operation of Highland Park Rehabilitation and Nursing Center, an 80-bed residential health care facility in Wellsville. The facility also runs an adult day health care program for 21 people at another nearby site. It's one of two projects to be cons idered by the establishment committee of… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 14, 2020 Category: Biotechnology Authors: Tracey Drury Source Type: news

Thermo Fisher Gets into Companion Diagnostic Collaboration with Janssen
Thermo Fisher Scientific has signed an agreement with Janssen Biotech to co-develop a companion diagnostic in the oncology space. Janssen Biotech is one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The pact calls for both firms to work together to validate multiple biomarkers for use with Waltham, MA-based Thermo Fisher’s Oncomine Dx Target Test, which will be used to identify variant-positive patients for enrollment into clinical trials focused on non-small cell lung cancer. Right now, the Oncomine assay contains 46 cancer-related biomarkers. "The ability of the Oncomine Dx Targ...
Source: MDDI - March 12, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

National Library of Medicine Acquires the Papers of Louis W. Sullivan, MD
The National Library of Medicine (NLM) is honored to announce its acquisition of the papers of Louis W. Sullivan, MD, former United States Secretary of Health and Human Services (HHS). This is the first collection of papers from a former HHS Secretary, acquired by the NLM and will be part of the archival collections of the world's largest medical library and institute of the National Institutes of Health (NIH). (Source: NLM General Announcements)
Source: NLM General Announcements - March 12, 2020 Category: Databases & Libraries Source Type: news

Leading Psychedelic Pharmaceutical Company MindMed Forms New Board Committee To Evaluate Acquisitions And Scientific Collaborations
John Hopkins professor and psychedelics expert Matthew Johnson to act as senior advisor to committee NEW YORK, March 12, 2020 -- (Healthcare Sales & Marketing Network) -- Mind Medicine (MindMed) Inc. ("MindMed") has formed a Technology Evalua... Biopharmaceuticals, Neurology, Personnel Mind Medicine, MindMed, ibogaine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 12, 2020 Category: Pharmaceuticals Source Type: news

RadNet to acquire AI software firm DeepHealth
Imaging services provider RadNet has signed a definitive agreement to acquire...Read more on AuntMinnie.comRelated Reading: NIH awards $4.5M grant for AI, mammo RadNet forms partnership with AI developer RadNet inks Del. contract RadNet launches AI division with Nulogix acquisition RadNet inks deal to acquire Calif. radiology group RadNet signs with Southern California firm to expand reach (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 11, 2020 Category: Radiology Source Type: news

Optimizing Sample Acquisition with an On-Site Approach
Learn how third-party sample acquisition benefits clinical researchers and provides flexible options (Source: The Scientist)
Source: The Scientist - March 11, 2020 Category: Science Tags: The Marketplace Source Type: news

Overcoming Data Collection and System Challenges in Real World...
In this webinar, the speakers will discuss key challenges in data collection for Real World Studies, strategies and system features to help facilitate data acquisition as well as ways to manage data...(PRWeb March 11, 2020)Read the full story at https://www.prweb.com/releases/overcoming_data_collection_and_system_challenges_in_real_world_studies_upcoming_webinar_hosted_by_xtalks/prweb16971559.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 11, 2020 Category: Pharmaceuticals Source Type: news

FDA pauses international inspections due to COVID-19
The U.S. Food and Drug Administration (FDA) said it is postponing all inspections...Read more on AuntMinnie.comRelated Reading: FDA recognizes AI-based image acquisition software FDA proposes electronic 510(k) submission template FDA seeks help to prevent vaping-related lung injuries FDA takes action to counter novel coronavirus FDA to host workshop on medical applications of AR, VR (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 10, 2020 Category: Radiology Source Type: news

Align Technology to acquire dental software company Exocad for €376M in cash
Align Technology Inc. entered an agreement to acquire Exocad Global Holdings GmbH, a privately held dental software company, for about €376 million in cash.Exocad develops computer-aided design and computer-aided manufacturing, or CAD/CAM, software to manage workflows in dental labs and dental practices.Align said the acquisition strengthens its digital platform, which includes tools and features for diagnostic, restorative, implant and orthodontic workflows.Under the deal, Align will pay about €376 million in cash to acquire Darmstadt, Germany-based Exocad, which is majority-owned by Carlyle Europe Technology Pa...
Source: Dental Technology Blog - March 10, 2020 Category: Dentistry Source Type: news